Iveric Bio Announces Presentation of Post-Hoc Analysis at Ma

10.06.2022 - IVERIC bio, Inc. (Nasdaq: ISEE) announced today a post-hoc analysis from the Zimura (avacincaptad pegol) GATHER1 clinical trial which explored enhanced Optical Coherence Tomography (OCT) image analysis to examine the effect of Zimura on change in ... Seite 1

Related Keywords

Iveric Bio , Christopher Simms , Justisp Ehlers , Leona Campane Center , Imaging Research , Cole Eye Institute , Chief Commercial Officer , Image Guided Surgery , Advanced Imaging Research ,